Clinical Trials on Solid Carcinoma in Taiwan

Total 1355 results

Suzhou Kintor Pharmaceutical Inc,
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Recruiting

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

Solid Tumor

Taiwan
Polaris Group

Terminated

Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers

Advanced Solid Cancers

Taiwan
Belx Bio-Pharmaceutical (Taiwan) Corporation
A2 Healthcare Taiwan Corporation

Terminated

Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients

Advanced Solid Tumors

Taiwan
SynCore Biotechnology Co., Ltd.

Completed

A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy

Solid Tumors

Taiwan
Taivex Therapeutics Corporation

Recruiting

Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors

Advanced Solid Tumor

Taiwan
TransThera Sciences (Nanjing), Inc.

Completed

Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Taiwan
PharmaEngine

Completed

Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors

Refractory Solid Tumors

Taiwan
Taivex Therapeutics Corporation

Active, not recruiting

Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

Taiwan
National Health Research Institutes, Taiwan
National Cheng-Kung University Hospital

Completed

Sorafenib Plus S-1 in Advanced Solid Tumors

Advanced Solid Tumors

Taiwan
National Health Research Institutes, Taiwan
National Cheng-Kung University Hospital

Recruiting

Neoantigen Derived DCs as Cancer Treatment

Solid Tumor | Refractory Tumor

Taiwan
Anbogen Therapeutics, Inc.

Recruiting

Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients

Non Small Cell Lung Cancer | Advanced Solid Tumor | HER2 Mutations

Taiwan
Henlix, Inc

Unknown

Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status

Solid Tumor, Adult

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Chang Gung Memorial Hospital; Kaohsiung... and other collaborators

Completed

Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients

Neuroendocrine Carcinomas

Taiwan
Taivex Therapeutics Corporation

Completed

An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

Taiwan
SciClone Pharmaceuticals International (Cayman)...
Parexel; National Cheng-Kung University Hospital

Unknown

An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study

Non-Small Cell Lung Cancer | Advanced Solid Tumor

Taiwan
Taivex Therapeutics Corporation

Terminated

Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

Taiwan
National Health Research Institutes, Taiwan
China Medical University Hospital; Chang Gung Memorial Hospital; National Cheng-Kung... and other collaborators

Completed

A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma

Oral Cancer

Taiwan
Chimei Medical Center

Completed

SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy

Hepatocellular Carcinoma

Taiwan
TaiRx, Inc.

Completed

Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients

Carcinoma | Advanced Cancer

Taiwan
National Cheng-Kung University Hospital

Completed

Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy

Cancer Stem Cell

Taiwan
National Cheng-Kung University Hospital

Completed

The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency Ablation

Liver Cancer | Post Ablation Syndrome

Taiwan
Suzhou Kintor Pharmaceutical Inc,

Completed

Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)

HCC | Metastatic Hepatocellular Carcinoma | Combinations of Drugs; Dependence

Taiwan
China Medical University Hospital

Unknown

Combined Radiotherapy and Sorafenib in Patients With Hepatoma

Hepatocellular Carcinoma

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; National Cheng-Kung...

Not yet recruiting

Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies (T4222)

Hepatocellular Carcinoma

Taiwan
National Health Research Institutes, Taiwan
Novartis

Unknown

Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Taiwan
S&T Biomed Co., Ltd.

Completed

Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer

Oral Squamous Cell Carcinoma

Taiwan
Polaris Group

Completed

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors

Taiwan, United States
National Cheng-Kung University Hospital
National Cheng Kung University; The Industrial Technology Research Institute

Completed

Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy

Cancer of Liver

Taiwan
National Cheng-Kung University Hospital
National Cheng Kung University; National Research Program for Biopharmaceuticals... and other collaborators

Completed

Taiwan ACE Beads for Hepatoma Embolization Therapy

Cancer of Liver

Taiwan
Merck KGaA, Darmstadt, Germany
Choice Pharma Taiwan

Completed

A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)

Carcinoma, Squamous Cell of Head and Neck

Taiwan
G&E Herbal Biotechnology Co., LTD

Completed

Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis (AK)

Actinic Keratosis | Bowen's Disease

Taiwan
InnoPharmax Inc.

Completed

Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas

Advanced Solid Malignancies | Malignant Lymphomas

Taiwan
T-ACE Medical Co., Ltd

Recruiting

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Taiwan
China Medical University Hospital

Unknown

Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

Taiwan
SynCore Biotechnology Co., Ltd.

Terminated

Study of SCB01A in Patient With Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma

Taiwan
National Cheng-Kung University Hospital

Unknown

Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer

Non-Small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Not yet recruiting

Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.

Unresectable Hepatocellular Carcinoma | Pembrolizumab | Stereotactic Body Radiotherapy | Lenvatinib

Taiwan
National Cheng-Kung University Hospital

Terminated

Metformin in Stage IV Lung Adenocarcinoma

Non-small Cell Lung Cancer

Taiwan
TaiRx, Inc.

Recruiting

CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Advanced Cancer

Taiwan
Great Novel Therapeutics Biotech & Medicals Corporation

Recruiting

Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC)

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Recruiting

Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC)

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; China Medical University Hospital; Taipei... and other collaborators

Recruiting

The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan

Oropharyngeal Squamous Cell Carcinoma

Taiwan
MegaPro Biomedical Co. Ltd.

Completed

The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma

Magnetic Resonance Imaging

Taiwan
Genzyme, a Sanofi Company

Completed

Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; Chang Gung Memorial... and other collaborators

Terminated

A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma

Hepatocellular Carcinoma

Taiwan
National Health Research Institutes, Taiwan
China Medical University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical... and other collaborators

Enrolling by invitation

BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study) (BEAR)

Esophageal Squamous Cell Carcinoma (ESCC)

Taiwan
National Taiwan University Hospital

Completed

Selumetinib in Combination With Gefitinib in NSCLC Patients

Non-small Cell Lung Cancer (NSCLC)

Taiwan
National Taiwan University Hospital

Completed

AUY922 in Patient With Stage IV NSCLC (NSCLC)

Non-small Cell Lung Cancer (NSCLC)

Taiwan
National Cheng-Kung University Hospital
G&E Herbal Biotechnology Co., LTD

Completed

SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma

Genital Warts | Vulvar Intraepithelial Neoplasia

Taiwan
Eli Lilly and Company

Completed

A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

Carcinoma, Hepatocellular

Taiwan

Clinical Trials on Solid Carcinoma in Taiwan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations